2025-02-21 - Analysis Report
## Merck & Co Inc (MRK) Stock Review

**0. Key Figures & Initial Analysis:**

Merck & Co Inc (MRK) is a leading pharmaceutical company.  The provided data shows a significant underperformance compared to the S&P 500 (VOO) over the measured period.  Further analysis is needed to determine the underlying causes.

**1. Performance Comparison with S&P 500 (VOO):**

* **MRK Cumulative Return:** 36.60%
* **VOO Cumulative Return:** 121.84%
* **Return Difference:** -85.2%  (MRK underperformed VOO significantly)
* **Relative Divergence:** 0.0 (This indicates MRK is at the lower bound of its historical range of underperformance relative to VOO).

The table below shows the Alpha and Beta for different time periods.  Alpha measures excess return over the benchmark (S&P 500), while Beta indicates the volatility relative to the benchmark.  High Beta indicates higher volatility.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | -2.0% | 11.8% | -0.1 | 110.1 |
| 2016-2018  | 46.0% | 11.8% | 0.5 | 154.1 |
| 2017-2019  | 44.0% | 11.8% | 0.3 | 188.4 |
| 2018-2020  | 32.0% | 9.4% | 0.2 | 174.8 |
| 2019-2021  | 3.0% | 14.3% | 0.2 | 177.9 |
| 2020-2022  | 47.0% | 14.3% | 0.2 | 265.8 |
| 2021-2023  | 55.0% | 14.3% | 0.3 | 268.4 |
| 2022-2024  | 21.0% | 9.5% | 0.3 | 251.7 |
| 2023-2025  | -50.0% | 15.6% | 0.2 | 210.0 |

Note the significant variation in CAGR and Alpha across different periods, indicating periods of both strong outperformance and underperformance. Beta is consistently high, suggesting MRK's price is considerably more volatile than the S&P 500.

**2. Recent Price Movement:**

* **Closing Price:** $83.01
* **5-Day Moving Average:** $85.21
* **20-Day Moving Average:** $92.75
* **60-Day Moving Average:** $97.45

The price is below all three moving averages, suggesting a bearish trend.

**3. Technical Indicators:**

* **RSI:** 12.95 (Extremely oversold; often signals potential reversal, but not guaranteed)
* **PPO:** -1.25 (Negative, indicating bearish momentum)
* **20-Day Relative Divergence Change:** -0.6 (Short-term downward trend)
* **Expected Return (vs. S&P 500):** 750.7% (This exceptionally high figure needs further clarification on its calculation and assumptions.  It's crucial to understand the basis for this projection.)


**4. Recent Earnings Analysis:**

| Date       | EPS     | Revenue       |
|------------|---------|----------------|
| 2024-11-06 | $1.25   | $16.66 B       |
| 2024-08-05 | $2.15   | $16.11 B       |
| 2024-05-03 | $1.88   | $15.78 B       |
| 2023-11-03 | $1.87   | $15.96 B       |
| 2024-11-06 | $1.87   | $15.96 B       |


There appears to be a duplicated entry for 2024-11-06.  Revenue shows modest growth, but EPS is fluctuating.  A more in-depth analysis is needed, including a comparison with previous years' earnings and industry benchmarks.

**5. Financial Information:**

The absence of "Total Revenue" and "Gross Profit" data prevents a comprehensive financial analysis.  This is a critical gap in the provided data.

**6. Overall Analysis:**

MRK has significantly underperformed the S&P 500 over the period analyzed, indicated by the large negative return difference. Technical indicators (RSI, PPO) show bearish signals, while the price is trading below its moving averages.  The provided earnings data shows some variability and needs further context. The highly optimistic projected return requires thorough investigation.  The lack of key financial data limits a comprehensive assessment.  To gain a complete understanding, more financial data (particularly total revenue and gross profit), detailed earnings analysis compared to previous years and competitors, and a justification for the exceptionally high expected return are necessary.
